Cargando…

Improved Rod Sensitivity as Assessed by Two-Color Dark-Adapted Perimetry in Patients With RPE65-Related Retinopathy Treated With Voretigene Neparvovec-rzyl

PURPOSE: The purpose of this study was to evaluate rod-mediated function with two-color dark-adapted perimetry (2cDAP) in patients with RPE65-related retinopathy treated with voretigene neparvovec-rzyl. METHODS: Following dilation and dark adaptation, 2cDAP and FST were performed. The 2cDAP was meas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ku, Cristy A., Igelman, Austin D., Huang, Samuel J., Vasconcelos, Huber, da Palma, Mariana Matioli, Bailey, Steven T., Lauer, Andreas K., Weleber, Richard G., Yang, Paul, Pennesi, Mark E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2023
Materias:	Retina
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117223/ https://www.ncbi.nlm.nih.gov/pubmed/37058101 http://dx.doi.org/10.1167/tvst.12.4.17

Ejemplares similares

Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Inherited Retinal Disease
por: Johnson, Scott, et al.
Publicado: (2019)

Prospect of retinal gene therapy following commercialization of voretigene neparvovec-rzyl for retinal dystrophy mediated by RPE65 mutation
por: Ameri, Hossein
Publicado: (2018)

Bilateral exudative retinal detachments after subretinal gene therapy with voretigene neparvovec-rzyl for RPE65 Leber Congenital Amaurosis
por: Lidder, Alcina K., et al.
Publicado: (2023)

Retinal Pigment Epithelium Atrophy After Subretinal Voretigene Neparvovec-rzyl for RPE65-Related Disease: A 6-Month Follow-Up
por: Giansanti, Fabrizio, et al.
Publicado: (2022)

Cost Effectiveness of Voretigene Neparvovec for RPE65-Mediated Inherited Retinal Degeneration in Germany
por: Uhrmann, Matthias Fritz, et al.
Publicado: (2020)

An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK
por: Viriato, Daniel, et al.
Publicado: (2020)

Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland
por: Bhadhuri, Arjun, et al.
Publicado: (2022)

Voretigene Neparvovec for the Treatment of RPE65-associated Retinal Dystrophy: Consensus and Recommendations from the Korea RPE65-IRD Consensus Paper Committee
por: Han, Jinu, et al.
Publicado: (2023)

Voretigene neparvovec for inherited retinal dystrophy
Publicado: (2021)

Visual function and retinal changes after voretigene neparvovec treatment in children with biallelic RPE65-related inherited retinal dystrophy
por: Testa, Francesco, et al.
Publicado: (2022)

Choroideremia Carriers: Dark-Adapted Perimetry and Retinal Structures
por: Parmann, Rait, et al.
Publicado: (2022)

Outcomes and Adverse Effects of Voretigene Neparvovec Treatment for Biallelic RPE65-Mediated Inherited Retinal Dystrophies in a Cohort of Patients from a Single Center
por: Kiraly, Peter, et al.
Publicado: (2023)

Voretigene Neparvovec in Retinal Diseases: A Review of the Current Clinical Evidence
por: Gao, Jie, et al.
Publicado: (2020)

Chorioretinal atrophy following voretigene neparvovec despite the presence of fundus autofluorescence
por: Kolesnikova, Masha, et al.
Publicado: (2022)

Voretigene Neparvovec and Gene Therapy for Leber’s Congenital Amaurosis: Review of Evidence to Date
por: Padhy, Srikanta Kumar, et al.
Publicado: (2020)

Spatial and temporal resolution of the photoreceptors rescue dynamics after treatment with voretigene neparvovec
por: Stingl, Krunoslav, et al.
Publicado: (2022)

RPE65-Associated Retinopathies in the Italian Population: A Longitudinal Natural History Study
por: Testa, Francesco, et al.
Publicado: (2022)

Voretigene Neparvovec Gene Therapy in Clinical Practice: Treatment of the First Two Italian Pediatric Patients
por: Testa, Francesco, et al.
Publicado: (2021)

Rapamycin Inhibits Light-Induced Necrosome Activation Occurring in Wild-Type, but not RPE65-Null, Mouse Retina
por: Lu, Chunfeng, et al.
Publicado: (2022)

Rod and Cone Dark Adaptation in Congenital Aniridia and Its Association With Retinal Structure
por: Pedersen, Hilde R., et al.
Publicado: (2023)

Fluorescence Lifetimes and Spectra of RPE and Sub-RPE Deposits in Histology of Control and AMD Eyes
por: Schultz, Rowena, et al.
Publicado: (2020)

Fundus Camera-Delivered Light-Induced Retinal Degeneration in Mice With the RPE65 Leu450Met Variant is Associated With Oxidative Stress and Apoptosis
por: Zhong, Xin, et al.
Publicado: (2016)

The Role of ERK1/2 Activation in Sarpogrelate-Mediated Neuroprotection
por: Ku, Cristy A., et al.
Publicado: (2018)

Assessing the Accuracy, Quality, and Readability of Patient Accessible Online Resources Regarding Ocular Gene Therapy and Voretigene Neparvovec
por: Davuluri, Swetha, et al.
Publicado: (2021)

Allogeneic iPSC-Derived RPE Cell Graft Failure Following Transplantation Into the Subretinal Space in Nonhuman Primates
por: McGill, Trevor J., et al.
Publicado: (2018)

An In Silica Model for RPE Loss Patterns in Choroideremia
por: Young, Benjamin K., et al.
Publicado: (2021)

Effect of Pharmacological Pupil Dilation on Dark-Adapted Perimetric Sensitivity in Healthy Subjects Using an Octopus 900 Perimeter
por: Igelman, Austin D., et al.
Publicado: (2021)

Suppression of cGMP-Dependent Photoreceptor Cytotoxicity With Mycophenolate Is Neuroprotective in Murine Models of Retinitis Pigmentosa
por: Yang, Paul, et al.
Publicado: (2020)

Gene Therapy with Voretigene Neparvovec Improves Vision and Partially Restores Electrophysiological Function in Pre-School Children with Leber Congenital Amaurosis
por: Gerhardt, Maximilian J., et al.
Publicado: (2022)

Rhythmic Regulation of Photoreceptor and RPE Genes Important for Vision and Genetically Associated With Severe Retinal Diseases
por: Vancura, Patrick, et al.
Publicado: (2018)

Comparison of human amniotic membrane decellularisation approaches for hESC-derived RPE cells culture
por: Daniele, Elena, et al.
Publicado: (2022)

Dasatinib Plus Quercetin Alleviates Choroid Neovascularization by Reducing the Cellular Senescence Burden in the RPE–Choroid
por: Wang, Yinhao, et al.
Publicado: (2023)

The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A Gene
por: Birch, David G., et al.
Publicado: (2022)

Extensive Sub-RPE Complement Deposition in a Nonhuman Primate Model of Early-Stage Diabetic Retinopathy
por: Fan, Shuxin, et al.
Publicado: (2021)

Genotype Phenotype Correlation and Variability in Microcephaly Associated With Chorioretinopathy or Familial Exudative Vitreoretinopathy
por: Shurygina, Maria F., et al.
Publicado: (2020)

Rods Contribute to Visual Behavior in Larval Zebrafish
por: Venkatraman, Prahatha, et al.
Publicado: (2020)

Multimodal Fundus Imaging of Sodium Iodate-Treated Mice Informs RPE Susceptibility and Origins of Increased Fundus Autofluorescence
por: Zhao, Jin, et al.
Publicado: (2017)

Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy
por: Song, Yinting, et al.
Publicado: (2021)

Loss of High-Mobility Group Box 1 (HMGB1) Protein in Rods Accelerates Rod Photoreceptor Degeneration After Retinal Detachment
por: Ross, Bing X., et al.
Publicado: (2020)

Prospective Evaluation of Patients With X-Linked Retinoschisis During 18 Months
por: Pennesi, Mark E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_imsnip6f36avj0fg79r91b926l